JPH06172782A - Powder of fat and oil containing highly unsaturated fatty acid - Google Patents

Powder of fat and oil containing highly unsaturated fatty acid

Info

Publication number
JPH06172782A
JPH06172782A JP4330613A JP33061392A JPH06172782A JP H06172782 A JPH06172782 A JP H06172782A JP 4330613 A JP4330613 A JP 4330613A JP 33061392 A JP33061392 A JP 33061392A JP H06172782 A JPH06172782 A JP H06172782A
Authority
JP
Japan
Prior art keywords
oil
fat
acid
fatty acid
pufa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP4330613A
Other languages
Japanese (ja)
Inventor
Yasuyuki Takagaki
康幸 高垣
Katsuyuki Nishioka
功志 西岡
Mitsumasa Mansou
三正 万倉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IKEDA SHIYOKUKEN KK
Original Assignee
IKEDA SHIYOKUKEN KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IKEDA SHIYOKUKEN KK filed Critical IKEDA SHIYOKUKEN KK
Priority to JP4330613A priority Critical patent/JPH06172782A/en
Publication of JPH06172782A publication Critical patent/JPH06172782A/en
Withdrawn legal-status Critical Current

Links

Abstract

PURPOSE:To obtain fat and oil powder having high oxidation stability by using a fat and oil containing highly unsaturated fatty acids and monoglycerides. CONSTITUTION:A fat and oil containing (at least 0.1wt.%) monoglyceride containing highly unsaturated fatty acids such as alpha-linolenic acid, gamma-linolenic acid, dihomo-gamma-linolenic acid, arachidonic acid, eicosapentaenoic acid and docosahexanoic acid as the constituent fatty acids is mixed with a phospholipid and an antioxidant such as tocopherol. The obtained mixture is uniformly emulsified and dispersed in a solution of an excipient comprising a protein such as casein or soy been protein, its decomposition product and a sugar such as milk sugar or starch. The obtained dispersion is dried by freeze drying or air drying to obtain the fat and oil powder of high oxidation stability.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は高度不飽和脂肪酸含有油
脂粉末に関し、特に酸化安定性に優れた高度不飽和脂肪
酸含有油脂粉末に関する。
FIELD OF THE INVENTION The present invention relates to a highly unsaturated fatty acid-containing oil and fat powder, and more particularly to a highly unsaturated fatty acid-containing oil and fat powder having excellent oxidation stability.

【0002】[0002]

【従来の技術】高度不飽和脂肪酸(以後、PUFAと略記)
はその広範な生理活性から、食品、医薬品、飼料等への
利用が考えられており、すでに、実施されている分野も
ある(「機能性脂質の開発と応用」,佐藤清隆他監修,
シーエムシー,(1992))。
BACKGROUND OF THE INVENTION Polyunsaturated fatty acids (hereinafter abbreviated as PUFA)
Due to its wide range of physiological activities, it is considered to be used in foods, pharmaceuticals, feeds, etc., and in some fields it has already been implemented ("Development and application of functional lipids", supervised by Kiyotaka Sato et al.,
CMC, (1992)).

【0003】ここで、PUFAとは、α−リノレン酸、γ−
リノレン酸、ジホモ−γ−リノレン酸、アラキドン酸、
エイコサペンタエン酸、ドコサヘキサエン酸から選ばれ
る1種類又は2種類以上のもので構成される脂肪酸群を
指す。
Here, PUFA means α-linolenic acid, γ-
Linolenic acid, dihomo-γ-linolenic acid, arachidonic acid,
It refers to a fatty acid group composed of one or more selected from eicosapentaenoic acid and docosahexaenoic acid.

【0004】[0004]

【発明が解決しようとする課題】しかし、一般に、PUFA
はきわめて酸化が速いため、現在市販されている製品の
多くはゼラチンソフトカプセルなどに封入されていた
り、窒素ガス封入の容器中で低温下で保管されており、
上記用途に用いる場合制約がある。かかる問題点解決の
ため、酸化安定性の高いPUFA含有油脂粉末の製造法に関
して、特開昭60-49097号, 特開昭60-49097号, 特開昭62
-126933 号, 特開昭 62-158213号, 特開昭 63-44844
号, 特開平3-297364号などの方法が提案されているが、
これらの方法では酸化の進行を妨げるには不十分であ
る。
However, in general, PUFA
Because of its extremely fast oxidation, most of the products currently on the market are enclosed in gelatin soft capsules, etc., or stored at low temperature in a container filled with nitrogen gas,
There are restrictions when used for the above purposes. In order to solve such problems, a method for producing a PUFA-containing oil / fat powder having high oxidation stability is disclosed in JP-A-60-49097, JP-A-60-49097, and JP-A-62-49097.
-126933, JP 62-158213, JP 63-44844
No. 3, JP-A-3-297364 and other methods have been proposed,
These methods are insufficient to prevent the progress of oxidation.

【0005】一方、モノグリセリド(以後、MGと略
記)は乳化剤として広範な産業分野で利用されており、
食品用にもグリセリン脂肪酸エステルとして大量に使用
されている(「食品用乳化剤と乳化技術」、衛生技術会
(1979))。通常、PUFAはグリセリド(主に、トリグリセ
リド、以後、TGと略記))の形で存在しているが、こ
れを酵素的に、又は、非酵素的に加水分解することによ
りMGを含むPUFA(以後、PUFA- MGと略記)を調整出
来る。MGを酵素的に調整するために、例えば、リパー
ゼを触媒としたTGの加水分解法(特開昭 60-102192
号, 特開昭 62-228289号, 特開平3-103499号, 特開平3-
108489号,特開平3-187385号など)、エステル交換(合
成)法(特開昭 59-118094号, 特開昭 59-118095号, 特
開昭 61-257192号, 特開昭62-201591 号, 特開昭 63-29
6698号, 特開平3-262492号など)等々多数の方法が公知
となっている。また、MGを非酵素的に調整するため
に、「食品用乳化剤と乳化技術、衛生技術会(1979)」、
特開平1-268663号等に述べられた方法を始めとして多数
の方法が公知となっている。
On the other hand, monoglyceride (hereinafter abbreviated as MG) is used as an emulsifier in a wide range of industrial fields.
It is also used in large quantities as glycerin fatty acid ester for foods ("Food emulsifiers and emulsification technology", Hygiene Technical Association).
(1979)). Usually, PUFA is present in the form of glyceride (mainly triglyceride, hereinafter abbreviated as TG). However, PUFA containing MG (hereinafter referred to as “FAFA”) is hydrolyzed enzymatically or nonenzymatically. , PUFA-MG) can be adjusted. For enzymatically adjusting MG, for example, a lipase-catalyzed hydrolysis method of TG (JP-A-60-102192).
No. 6, JP-A-62-228289, JP-A-3-103499, JP-A-3-
108489, JP-A-3-187385, etc.), transesterification (synthesis) method (JP-A-59-118094, JP-A-59-118095, JP-A-61-257192, JP-A-62-201591) , JP-A-63-29
6698, JP-A-3-262492, etc.) and many other methods are known. Moreover, in order to non-enzymatically adjust MG, "Emulsifiers for Food and Emulsification Technology, Hygiene Technology Society (1979)",
Many methods are known, including the method described in Japanese Patent Laid-Open No. 1-268663.

【0006】しかしながら、PUFA- MGを含む油脂を粉
末化した場合の酸化安定性に関しては知られていない。
大豆レシチン、卵黄レシチン等に代表されるリン脂質類
は、特に、ω-3系のPUFAの酸化防止に有効であること
が、特開昭 61-112020号, 特開平 3-297364 号, 原節子
他:油化学、41, 130-135(1992) 等々に示されている通
り公知となっている。しかしながら、PUFA- MGを含む
油脂粉末に対するリン脂質類添加の酸化防止効果に関し
ては知られていない。
However, nothing is known about the oxidative stability of fats and oils containing PUFA-MG.
Phospholipids typified by soybean lecithin and egg yolk lecithin are particularly effective in preventing the oxidation of ω-3 PUFA, as disclosed in JP-A-61-112020, JP-A-3-297364 and Hara Setsuko. Others: Known as shown in Oil Chemistry, 41, 130-135 (1992), etc. However, the antioxidant effect of the addition of phospholipids to the oil / fat powder containing PUFA-MG is not known.

【0007】以上に述べた如く、PUFAの粉末化、MGの
調整法、PUFAに対するリン脂質類添加の酸化防止効果等
に関し、個々には知られていたが、これらを組み合わせ
て酸化安定性に優れたPUFA含有粉末を得ることは知られ
ておらず、従って、PUFAの用途拡大には限界があった。
As described above, it has been known individually about the powdering of PUFA, the method of adjusting MG, the antioxidant effect of adding phospholipids to PUFA, etc. It has not been known to obtain PUFA-containing powders, and thus there have been limits to the expansion of PUFA applications.

【0008】本発明は、上記の如き従来の課題に鑑みて
なされたもので、その目的とするところは、PUFAを生理
活性を有する機能性油脂成分として、食品、医薬品、飼
料等へ用い、用途を拡大するに当たり、酸化安定性に優
れた高度不飽和脂肪酸含有油脂粉末を提供することにあ
る。
The present invention has been made in view of the conventional problems as described above, and an object thereof is to use PUFA as a functional oil component having physiological activity in foods, pharmaceuticals, feeds, etc. In expanding the above, it is an object to provide a highly unsaturated fatty acid-containing oil / fat powder having excellent oxidation stability.

【0009】[0009]

【課題を解決するための手段】上記目的を達成するた
め、酸化安定性に優れたPUFA粉末を得るため鋭意研究を
重ねた結果、PUFA- MGを含む油脂をリン脂質、トコフ
ェロール等の抗酸化剤と混合した後、カゼイン、大豆タ
ンパク等のタンパク質及びそれらの分解物、又は、糖質
等に均質に乳化・分散させ、このものをスプレードライ
(SD、噴霧乾燥)、フリーズドライ(FD、凍結乾
燥)、熱風乾燥(AD)等の手段で乾燥することによ
り、酸化安定性に優れたPUFA含有油脂粉末を得ることの
出来る事を見出し、本発明に到達した。以下に詳細を述
べる。
[Means for Solving the Problems] In order to achieve the above object, as a result of intensive studies to obtain PUFA powders having excellent oxidation stability, as a result, fats and oils containing PUFA-MG have been added as antioxidants such as phospholipids and tocopherols. After mixing with, protein such as casein, soybean protein, etc. and their degradation products or sugar, etc. are uniformly emulsified and dispersed, and this is spray dried (SD, spray dried), freeze dried (FD, freeze dried). ), It was found that a PUFA-containing oil / fat powder excellent in oxidation stability can be obtained by drying by means such as hot air drying (AD), and the present invention has been accomplished. Details will be described below.

【0010】生理活性を有するPUFA原料としては、α−
リノレン酸、γ−リノレン酸、ジホモ−γ−リノレン
酸、アラキドン酸、エイコサペンタエン酸、ドコサヘキ
サエン酸等のPUFAを1分子以上その構成脂肪酸として有
する全てのグリセロ脂質が含まれる。例えば、アマニ
油、シソ油( α−リノレン酸原料)、糸状菌等の菌体脂
質(γ−リノレン酸、ジホモ−γ−リノレン酸、アラキ
ドン酸、エイコサペンタエン酸原料)、魚油(エイコサ
ペンタエン酸、ドコサヘキサエン酸原料)などがあげら
れるが、これらの機能性PUFAを構成脂肪酸中 5.0%(重
量比)以上含むグリセロ脂質であれば全て本発明で用い
られるPUFA原料と見做される。
As a PUFA raw material having physiological activity, α-
All glycerolipids having one or more PUFA molecules such as linolenic acid, γ-linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, eicosapentaenoic acid and docosahexaenoic acid as its constituent fatty acids are included. For example, linseed oil, perilla oil (α-linolenic acid raw material), fungal lipids such as filamentous fungi (γ-linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, eicosapentaenoic acid raw material), fish oil (eicosapentaenoic acid, Docosahexaenoic acid raw material) and the like, and any glycerolipid containing 5.0% (weight ratio) or more of these functional PUFAs in the constituent fatty acids is regarded as the PUFA raw material used in the present invention.

【0011】PUFA-MG を含む油脂は酵素的に、又は、非
酵素的に調整される。PUFA-MG を含む油脂の酵素的調整
方法として、例えば、グリセロ脂質としてTGを用いる
場合、触媒としてリパーゼを用いるのが一般的であり、
前述の通り公知である。処理方法として、バッチ式、連
続式(バイオリアクター式)等幾多の方法が知られてい
るが、本発明においてはいかなる酵素的手段であれ、製
品となる油脂中に0.1%以上のMGが含有されていれば
目的を達することが出来る。PUFA-MG を含む油脂の非酵
素的調整方法として、例えば、TGを原料とした場合、
(部分)加水分解法に基づく幾多もの方法(「新版脂肪
酸化学」、稲葉恵一他編、幸書房、1981)があげられ
る。また、グリセリンとPUFA(及びそのエステル)を原
料とした場合、その合成法として、例えば、前述(特開
平1-268663号)の如く公知の手段が知られているが、本
発明においてはいかなる非酵素的手段であれ、製品とな
る油脂中に0.1%以上のMGが含有されていれば、「酸化
安定性の高い高度不飽和脂肪酸含有油脂粉末を得る」た
めの本発明の目的を達することが出来る。
Fats and oils containing PUFA-MG are prepared enzymatically or non-enzymatically. As a method for enzymatically adjusting fats and oils containing PUFA-MG, for example, when TG is used as glycerolipid, it is general to use lipase as a catalyst,
It is known as described above. As a treatment method, various methods such as a batch method and a continuous method (bioreactor method) are known. In the present invention, fat or oil to be a product contains 0.1% or more of MG by any enzymatic means. If you do, you can reach your goal. As a non-enzymatic method for preparing fats and oils containing PUFA-MG, for example, when TG is used as a raw material,
There are numerous methods based on the (partial) hydrolysis method (“New Edition Fatty Acid Chemistry”, Keiichi Inaba et al., Koshobo, 1981). Further, when glycerin and PUFA (and its ester) are used as raw materials, as a method for synthesizing them, known means such as the above-mentioned (Japanese Patent Laid-Open No. 1-268663) are known. Even if it is an enzymatic means, if 0.1% or more of MG is contained in the fat or oil to be the product, the object of the present invention to “obtain a highly unsaturated fatty acid-containing fat or oil powder having high oxidation stability” can be achieved. I can.

【0012】この様にして調整された0.1 %以上のPUFA
-MG を含む油脂は、必要に応じて脱酸、脱臭、脱色等の
諸工程により精製する。目的によっては、本発明の条件
を満たすために製品中のMG含有量を0.1 %以上とする
べく濃縮工程を加えても良い。これらの方法は成書
(「食用油脂製造の実際」、宮川高明著、幸書房、198
8;「総合脂質科学」、鹿山光編、恒星社厚生閣、198
9)に詳しく述べられている通りである。いずれにして
も、0.1 %以上のPUFA-MG を含む油脂を用いることが
「酸化安定性の高い高度不飽和脂肪酸含有油脂粉末を得
る」ための本発明の基本的要件の一つであり、食品とし
ての条件を満たす限りにおいて精製、濃縮工程が必ずし
も常に必要な訳ではない。
0.1% or more of PUFA adjusted in this way
-The oils and fats containing MG are refined by various processes such as deoxidation, deodorization and decolorization, if necessary. Depending on the purpose, in order to satisfy the conditions of the present invention, a concentration step may be added so that the MG content in the product is 0.1% or more. These methods are described in the book ("Actual production of edible oils and fats", written by Takaaki Miyakawa, Kou Shobo, 198).
8; "Comprehensive Lipid Science", Hikaru Kayama, Koseisha Koseikaku, 198
As detailed in 9). In any case, using fats and oils containing 0.1% or more of PUFA-MG is one of the basic requirements of the present invention for “obtaining highly unsaturated fatty acid-containing fats and oil powders with high oxidation stability”, and The purification and concentration steps are not always necessary as long as the above condition is satisfied.

【0013】この様にして調整された0.1 %以上のPUFA
-MG を含む油脂に対し、酸化安定性をより相乗的に高め
るため、リン脂質を 1.0%以上30.0%以下(重量比)加
えることができる。ここで、リン脂質とはグリセロリン
脂質、スフィンゴリン脂質、ホスホノ脂質等を指してい
るが、実際的には、価格、品質など産業的見地からグリ
セロリン脂質(主に、ホスファチジルコリン、ホスファ
チジルエタノールアミン、ホスファチジルセリン、ホス
ファチジルイノシトール及びこれらのリゾ体等々の混合
物)を用いる事が望ましい。グリセロリン脂質は、一般
に、大豆レシチン、卵黄レシチン等に多く含まれてお
り、食品、医薬品、飼料等の分野で使用されており、本
発明においてもリン脂質としてこれらのレシチン類を用
いることが出来る。市販レシチンは様々なグレード品
(リン脂質純度が異なる)から構成されているが、本発
明においては最終的なリン脂質含有量そのものが重要で
ある。
0.1% or more of PUFA adjusted in this way
-For oils and fats containing MG, phospholipids can be added in an amount of 1.0% or more and 30.0% or less (weight ratio) in order to enhance synergistically the oxidation stability. Here, the phospholipids refer to glycerophospholipids, sphingophospholipids, phosphonolipids, etc., but in reality, glycerophospholipids (mainly phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylserine, etc.) are used from an industrial viewpoint such as price and quality. , Phosphatidylinositol, and mixtures of these lyso forms and the like) are preferably used. Glycerophospholipids are generally contained in a large amount in soybean lecithin, egg yolk lecithin and the like, and are used in the fields of foods, pharmaceuticals, feeds, etc. In the present invention, these lecithins can be used as phospholipids. Although commercially available lecithin is composed of various grades (having different phospholipid purities), the final phospholipid content itself is important in the present invention.

【0014】0.1 %以上のPUFA-MG を含む油脂に対する
リン脂質添加量は1.0 %以下では酸化安定性に対し殆ど
効力を示さず、30.0%以上では粉末化後の物性面でブロ
ッキングなどの問題を生じ、官能的にもレシチン臭が強
くなるなどの問題が生じるため、 1.0%以上30.0%以下
(重量比)加えることが望ましい。
When the amount of phospholipid added to fats and oils containing 0.1% or more of PUFA-MG is 1.0% or less, there is little effect on oxidative stability, and when it is 30.0% or more, problems such as blocking due to physical properties after pulverization are caused. Therefore, it is desirable to add 1.0% or more and 30.0% or less (weight ratio) because it causes a problem that the lecithin odor becomes strong organoleptically.

【0015】別に併用する抗酸化剤としては、ビタミン
E(トコフェロール)、アスコルビン酸、パルミチン酸
アスコルビル、カテキン類、香辛料抽出物など幾多もの
種類が知られているが、目的に応じて使用する抗酸化剤
の種類、使用量などは任意に選択しても、本発明の基本
的要件とは矛盾しない。
As antioxidants to be used in combination, various kinds are known, such as vitamin E (tocopherol), ascorbic acid, ascorbyl palmitate, catechins, and spice extracts. Even if the kind of the agent and the amount used are arbitrarily selected, they do not contradict the basic requirements of the present invention.

【0016】一方、油脂粉末の製造方法は多くの手段が
公知である。特に、PUFAを含む油脂の粉末化に関して
は、特開昭60-49097号 ,特開昭62-126933 号, 特開昭63
-44844号, 特開平3-297364号などでも知られている通
り、賦形剤として蛋白質(カゼイン、カゼインナトリウ
ム、大豆蛋白、ゼラチン、牛乳、粉乳、ホエー、卵白
等)、糖質(澱粉、デキストリン、シクロデキストリ
ン、乳糖、ショ糖、麦芽糖、ブドウ糖、異性化糖、水添
麦芽糖、水添ブドウ糖、アラビアガム、グアガム、キサ
ンタンガム、トラガントガム、カラギーナン、ペクチ
ン、マンナン等)などが一般的に使用されるが、本発明
においては賦形剤の種類、混合比はいずれでも良い。粉
末化後の粉末中の油脂含有量は、粉末油脂としての製品
の特性上、また、前記機能性脂質がその生理活性を発現
出来る最低量として、1.0 %以上(重量比)であること
が必要である。
On the other hand, many means are known for producing oil and fat powder. Particularly, regarding the pulverization of fats and oils containing PUFA, JP-A-60-49097, JP-A-62-126933, and JP-A-63
-44844, Japanese Patent Application Laid-Open No. 3-297364, and the like, proteins (casein, sodium caseinate, soybean protein, gelatin, milk, milk powder, whey, egg white, etc.), sugars (starch, dextrin) as excipients. , Cyclodextrin, lactose, sucrose, maltose, glucose, isomerized sugar, hydrogenated maltose, hydrogenated glucose, arabic gum, guar gum, xanthan gum, tragacanth gum, carrageenan, pectin, mannan, etc. are generally used. In the present invention, any kind of excipient and mixing ratio may be used. The content of fats and oils in the powder after pulverization must be 1.0% or more (weight ratio) as the minimum amount that the functional lipid can express its physiological activity due to the characteristics of the product as a powdered fat and oil. Is.

【0017】上記原料は、例えば、予めタンパク質、糖
質等を溶解させた溶液中に、全固形分に対し 1.0%(重
量比)以上に相当するPUFA-MG 、及び、PUFA-MG に対し
1.0%以上30%以下(重量比)のリン脂質、PUFA-MG に
対し任意量の抗酸化剤を添加、混合した脂溶性成分を加
え、ホモミキサー(商品名)等で分散させ、乾燥前試料
とすることが出来る。この時、溶液中の全固形分量は限
定されないが、混合工程における機械的操作条件、乾燥
機の操作性、乾燥効率等々によりおのずから制約がある
ことは当然である。また、製品となる高度不飽和脂肪酸
含有油脂粉末の用途(食品、医薬品、飼料等)に応じ
て、フレーバー類、調味料、薬効成分、栄養成分等々を
別に添加する場合も本発明の範疇に含まれることは当然
である。
The above-mentioned raw materials are, for example, for PUFA-MG and PUFA-MG equivalent to 1.0% (weight ratio) or more based on the total solid content in a solution in which proteins, sugars and the like are previously dissolved.
1.0% or more and 30% or less (weight ratio) of phospholipids and PUFA-MG, an arbitrary amount of antioxidant is added, mixed fat-soluble components are added, dispersed with a homomixer (trade name), etc., and sample before drying Can be At this time, the total solid content in the solution is not limited, but it is naturally limited by mechanical operation conditions in the mixing step, operability of the dryer, drying efficiency, and the like. Further, depending on the intended use of the highly-unsaturated fatty acid-containing oil and fat powder used as a product (foods, pharmaceuticals, feeds, etc.), it is also included in the scope of the present invention when flavors, seasonings, medicinal ingredients, nutritional ingredients, etc. are added separately. It is natural that

【0018】上記混合溶液は、例えば、スプレードラ
イ、フリーズドライ、熱風乾燥等の公知の手段により乾
燥させ、粉末化することが出来る。本発明においては乾
燥方法そのものは、いかなる手段であれ本発明思想が制
約されることはない。
The above mixed solution can be dried and powdered by a known means such as spray drying, freeze drying, hot air drying and the like. In the present invention, the drying method itself does not limit the idea of the present invention by any means.

【0019】以上の方法により、酸化安定性の高い高度
不飽和脂肪酸含有油脂粉末を調整する事が出来る。そし
て、このものは、食品、医薬品、飼料等に利用した場
合、魚臭の発現、POV の上昇等が抑えられ、酸化安定性
の高い良好な品質の製品を得る事が出来る。
By the above method, a highly unsaturated fatty acid-containing oil / fat powder having high oxidation stability can be prepared. When this product is used for foods, pharmaceuticals, feeds, etc., the occurrence of fishy odor, the increase of POV, etc. are suppressed, and a product of good quality with high oxidative stability can be obtained.

【0020】[0020]

【作用】本発明では、モノグリセセドを含む高度不飽和
脂肪酸含有油脂中に存在するモノグリセリド含有量が重
量比で 0.1%以上としたので、酸化安定性に優れた高度
不飽和脂肪酸含有油脂粉末を得ることができる。
In the present invention, since the content of monoglyceride present in the highly unsaturated fatty acid-containing fats and oils containing monoglycedide is 0.1% or more by weight, the highly unsaturated fatty acid-containing fat and oil powder having excellent oxidation stability can be obtained. You can

【0021】[0021]

【実施例】次に、実施例により本発明を更に具体的に説
明するが、これらは例示であって、本発明はこれら実施
例に限定されるものではない。
EXAMPLES Next, the present invention will be described in more detail by way of examples, but these are examples and the present invention is not limited to these examples.

【0022】[実施例1] 0.1 %以上のPUFA-MG を含
む油脂の調整方法 本実施例においては、PUFAとしてエイコサペンタエン酸
(以後、EPAと略記)を例に選び、魚油からの0.1 %
以上のPUFA-MG を含む油脂の酵素的調整方法に関して述
べる。
[Example 1] Method for preparing fats and oils containing 0.1% or more of PUFA-MG In this example, eicosapentaenoic acid (hereinafter abbreviated as EPA) was selected as the PUFA, and 0.1% from fish oil was selected.
The method for enzymatically adjusting fats and oils containing PUFA-MG described above will be described.

【0023】1.使用する原料油脂 MG調整のための原料油脂として、EPA20(TG) (商品
名;池田糖化工業株式会社製)より大豆レシチン、天然
ビタミンEなどの配合成分を全て除いた後使用した。本
原料油脂はイワシ油より脱酸、脱色、濃縮、脱臭等の工
程にて精製された食用魚油で、下記性状を有していた。 MG純度(総脂質組成中) 不検出(TLC/FID 法) EPA純度(総脂肪酸組成中) 21.3%(ガスクロマト
グラフィー法) 酸価(AV) 0.1 (日本油化学協
会法) 過酸化物価(POV) 0.2 (日本油化学協
会法) 色調 淡黄色透明 臭い 特有の風味(魚臭)を
僅かに有す 上記性状から、本原料油脂は殆どがTGから構成されて
いるものと推定した。本原料油脂を以後「EPA20」
と称する。
1. Raw material oils and fats to be used As raw material oils and fats for MG adjustment, EPA20 (TG) (trade name; manufactured by Ikeda Gokuka Kogyo Co., Ltd.) was used after all the compounding components such as soybean lecithin and natural vitamin E were removed. The raw material oil and fat was edible fish oil refined from sardine oil in steps such as deoxidation, decolorization, concentration and deodorization, and had the following properties. MG purity (in total lipid composition) Undetected (TLC / FID method) EPA purity (in total fatty acid composition) 21.3% (gas chromatography method) Acid value (AV) 0.1 (Japan Oil Chemistry Association method) Peroxide value (POV) ) 0.2 (Japan Oil Chemistry Association method) Color tone Light yellow transparent odor Slightly peculiar flavor (fish odor) Based on the above properties, it was presumed that most of the raw material fats and oils were composed of TG. This raw material fat will be referred to as "EPA20".
Called.

【0024】2.MGの酵素的調整方法 上記原料油脂を酵素により部分加水分解し、MG含有量
0.1 %以上の「5.0 %以上のPUFAを含む油脂」を調整す
るに当たり、下記方法を用いた。
2. Enzymatic preparation method of MG The above-mentioned raw material fats and oils are partially hydrolyzed with an enzyme to give MG content.
The following method was used to adjust 0.1% or more of "fats and fats containing 5.0% or more of PUFA".

【0025】酵素は Rhizops niveus 由来のリパーゼを
使用した。反応溶液の組成(反応開始前のpH7.0 前
後)は下記の通りである。 原料油脂(EPA20) 49.5部 リパーゼ 0.5部 水 50.0部 合計 100.0部 反応は40℃で3時間行い、90〜95℃で10分間加
熱処理することにより反応を終了させた。この間、pH
調整は行わなかった。反応終了後の溶液から遠心分離法
(3000rpm 、10分間)により水分を除いた後、油脂分を
更に水蒸気蒸留、分子蒸留及び酸性白土処理等により精
製し、脱臭、脱色された下記性状の精製油を得た。 MG純度(総脂質組成中) 5.5 %(TLC/FID 法) EPA純度(総脂肪酸組成中) 21.2%(ガスクロマト
グラフィー法) 過酸化物価(POV) 0.2 (日本油化学協
会法) 酸価(AV) 42.9 (日本油化学協
会法) 色調 淡黄色透明 臭い 特有の風味(魚臭)を
僅かに有す 本品を以後「EPA20E(未脱酸油)」と称する。こ
のもののMG含有量は本発明で規定しているMG含有量
(0.1 %以上)、PUFA含有量(5.0 %以上)を共に満足
するものであった。
As the enzyme, lipase derived from Rhizops niveus was used. The composition of the reaction solution (pH around 7.0 before the start of the reaction) is as follows. Raw oil and fat (EPA20) 49.5 parts Lipase 0.5 part Water 50.0 parts Total 100.0 parts The reaction was carried out at 40 ° C for 3 hours, and the reaction was terminated by heating at 90 to 95 ° C for 10 minutes. During this time, pH
No adjustments were made. After removing water from the solution after the reaction by centrifugation (3000 rpm, 10 minutes), the oil and fat was further purified by steam distillation, molecular distillation, acid clay treatment, etc., and deodorized and decolorized purified oil of the following properties Got MG purity (in total lipid composition) 5.5% (TLC / FID method) EPA purity (in total fatty acid composition) 21.2% (gas chromatography method) Peroxide value (POV) 0.2 (Japan Oil Chemistry Association method) Acid value (AV 42.9 (Japan Oil Chemistry Association method) Color tone Light yellow transparent Smell This product has a slight peculiar flavor (fish odor) and is hereinafter referred to as "EPA20E (undeoxidized oil)". The MG content of this product satisfied both the MG content (0.1% or more) and the PUFA content (5.0% or more) specified in the present invention.

【0026】EPA20E(未脱酸油)は酵素反応の
際、TGの加水分解により生じた遊離脂肪酸がそのまま
残っているため、AVが高く、このことが食品への利用
範囲を限定する場合もあるため、これを更にアルカリ脱
酸法、分子蒸留法、真空蒸留法等により繰り返し処理
し、遊離脂肪酸を除きAVを低下させた下記性状の精製
油を得た。
EPA20E (undeoxidized oil) has a high AV because free fatty acids generated by the hydrolysis of TG remain during the enzymatic reaction, and this has a high AV, which may limit the range of use in foods. Therefore, this was further repeatedly treated by an alkali deoxidizing method, a molecular distillation method, a vacuum distillation method or the like to obtain a refined oil having the following properties in which free fatty acids were removed and AV was reduced.

【0027】 MG純度(総脂質組成中) 5.8%(TLC/FID 法) EPA純度(総脂肪酸組成中) 21.6%(ガスクロマト
グラフィー法) 過酸化物価(POV) 0.1 (日本油化学協
会法) 酸価(AV) 0.3 (日本油化学協
会法) 色調 淡黄色透明 臭い 特有の風味(魚臭)を
僅かに有す 本品を以後「EPA20E(脱酸済油)」と称する。こ
のもののMG含有量は本発明で規定しているMG含有量
(0.1 %以上)、PUFA含有量(5.0 %以上)を共に満足
するものであった。
MG purity (in total lipid composition) 5.8% (TLC / FID method) EPA purity (in total fatty acid composition) 21.6% (gas chromatography method) Peroxide value (POV) 0.1 (Japan Oil Chemistry Association method) Acid Value (AV) 0.3 (Japan Oil Chemistry Association method) Color tone Light yellow transparent Odor A slight peculiar flavor (fish odor) is referred to as "EPA20E (deoxidized oil)" hereinafter. The MG content of this product satisfied both the MG content (0.1% or more) and the PUFA content (5.0% or more) specified in the present invention.

【0028】この様にして得られたEPA20E(未脱
酸油)、EPA20E(脱酸済油)を使用目的(用途)
によって使い分けながら、EPA20を対象として以後
の実施例に示す試作を行った。なお、本実施例の場合は
EPAをPUFA-MG の例に用いているが、他のPUFA(本文
中に記載)の場合も同様のプロセスによって、それぞれ
のPUFA-MG の調整ができることは言うまでもない。
The EPA20E (undeoxidized oil) and EPA20E (deoxidized oil) thus obtained are used (purpose).
Prototypes shown in the following examples were carried out for the EPA 20 while properly using. In the case of the present embodiment, EPA is used as an example of PUFA-MG, but it goes without saying that each PUFA-MG can be adjusted by the same process in the case of other PUFAs (described in the text). .

【0029】[実施例2] 噴霧乾燥法(SD)による
PUFA含有油脂粉末の調整 下記処方(表1)にてEPA含有油脂粉末の調整を行
い、品質の比較を行った。
Example 2 By spray drying method (SD)
Preparation of PUFA-containing oil / fat powder The EPA-containing oil / fat powder was adjusted according to the following formulation (Table 1), and the quality was compared.

【表1】 すなわち、大豆タンパク、乳糖、及び澱粉を水 300部に
加えて、混合、溶解せしめ、この溶液を T.K. ホモミキ
サーMARK(特殊機化工業製)にて処理しながら、EPA20
、EPA20E(未脱酸油)、大豆レシチン等の脂溶性混合
物を少しづつ加え、全ての混合が終了した後、10000rpm
にて10分間、氷冷下にて均質化処理(乳化・分散)を行
った。続いて、この溶液をスプレードライヤー(パルビ
スミニスプレー(GA-21型),ヤマト科学製)により、下記
条件にて噴霧乾燥し、粉末を得た。 噴霧乾燥条件: 入口温度 180 ℃ 出口温度 100 ℃ 送液量 2.5 ml/min 噴霧圧力 1.2 kg/cm 2 得られた粉末の品質を表2に示す。固形分回収率は各区
共、65〜70%である。
[Table 1] That is, soybean protein, lactose, and starch are added to 300 parts of water, mixed and dissolved, and this solution is treated with TK Homomixer MARK (manufactured by Tokushu Kika Kogyo) while EPA20
, EPA20E (undeoxidized oil), soybean lecithin, etc. are added little by little, and after all mixing is completed, 10000 rpm
At 10 minutes, homogenization treatment (emulsification / dispersion) was performed under ice cooling. Subsequently, this solution was spray-dried under the following conditions with a spray dryer (Parbis mini spray (GA-21 type), manufactured by Yamato Scientific Co., Ltd.) to obtain a powder. Spray drying conditions: Inlet temperature 180 ° C Outlet temperature 100 ° C Liquid transfer rate 2.5 ml / min Spraying pressure 1.2 kg / cm 2 The quality of the obtained powder is shown in Table 2. The solid content recovery rate is 65 to 70% in each section.

【0030】[0030]

【表2】 上記粉末の品質を 40 ℃(開放静置)条件下にて30日後
比較したところ、表3に示す結果が得られた。
[Table 2] When the qualities of the above powders were compared after 30 days at 40 ° C. (open standing), the results shown in Table 3 were obtained.

【0031】官能評価は池田食研研究所員(5名)をパ
ネルとし、平均的な言語表現で示した。
The sensory evaluation was shown by an average linguistic expression with a panel of 5 members of Ikeda Institute for Food Research.

【0032】すなわち、ブランク(EPA20 +リン脂質)
とEPA20E(未脱酸油)区(リン脂質添加区)の比較をす
ると、粉末化直後及び30日経過後共に、MGを含む後者
においては POVが低く、かつ、官能評価の結果も良好で
あり、MGを含むPUFA含有油脂粉末の酸化安定性に関す
る本発明の意図が証明されている。更に、EPA20E(未脱
酸油)区について、リン脂質無添加区とリン脂質添加区
の比較をすると、リン脂質を含む後者においては、粉末
化直後及び30日経過後共に、 POVが低く、かつ、官能評
価の結果も良好であり、リン脂質を含むPUFA含有油脂粉
末の酸化安定性に関する本発明の効果が証明されてい
る。
That is, blank (EPA20 + phospholipid)
When comparing the EPA20E (undeoxidized oil) group (phospholipid-added group) and the powdered product and after 30 days, the latter containing MG has a low POV and good sensory evaluation results. The intent of the present invention on the oxidative stability of PUFA-containing fat powders containing MG has been demonstrated. Furthermore, when comparing the EPA20E (undeoxidized oil) group with the phospholipid-free group and the phospholipid-added group, the latter containing phospholipid had a low POV both immediately after pulverization and after 30 days, and The result of the sensory evaluation was also good, and the effect of the present invention on the oxidative stability of the PUFA-containing oil and fat powder containing phospholipids has been proved.

【0033】[0033]

【表3】 [実施例3] 凍結乾燥法(FD)によるPUFA含有油脂
粉末の調整 下記処方(表4)にてEPA含有油脂粉末の調整を行
い、品質の比較を行った。
[Table 3] [Example 3] Adjustment of PUFA-containing oil / fat powder by freeze-drying method (FD) The EPA-containing oil / fat powder was adjusted according to the following formulation (Table 4), and the quality was compared.

【0034】[0034]

【表4】 すなわち、カゼイン、アラビアガム及び澱粉を水 200部
に加えて、混合、溶解せしめ、この溶液を T.K. ホモミ
キサーMARK II (特殊機化工業(株)製)にて処理しな
がら、EPA20(V2) 、EPA20E(脱酸済油)、大豆レシチン
等の脂溶性混合物を少しづつ加え、全ての混合が終了し
た後、10000rpmにて10分間、氷冷下にて均質化処理(乳
化・分散)を行った。続いて、試料をポリ袋に厚み約1
cmとなる1うに入れ、マイナス25℃で予備凍結した。こ
の凍結した試料をフリーズドライヤー(共和真空技術製
テスト機)により、20時間(0.2 Torr以下, 最終品温 4
0℃)処理し、粉砕後、製品(粉末)を得た。
[Table 4] That is, casein, gum arabic, and starch were added to 200 parts of water, mixed and dissolved, and this solution was treated with TK Homomixer MARK II (manufactured by Tokushu Kika Kogyo Co., Ltd.) while EPA20 (V2), A fat-soluble mixture such as EPA20E (deoxidized oil) and soybean lecithin was added little by little, and after all mixing was completed, homogenization treatment (emulsification / dispersion) was performed at 10,000 rpm for 10 minutes under ice cooling. . Then, put the sample in a plastic bag with a thickness of about 1
The sample was placed in a centimeter of 1 cm and pre-frozen at -25 ° C. This frozen sample was freeze-dried for 20 hours (0.2 Torr or less, final product temperature 4
(0 ° C.) treatment and pulverization to obtain a product (powder).

【0035】得られた(製品)粉末の品質を表5に示
す。
Table 5 shows the quality of the obtained (product) powder.

【0036】[0036]

【表5】 上記粉末の品質を 40 ℃(開放静置)条件下にて30日後
比較したところ、表6に示す結果が得られた。官能評価
は池田食研研究所員(5名)をパネルとし、平均的な言
語表現で示した。
[Table 5] When the qualities of the above powders were compared after 30 days under the condition of 40 ° C. (open standing), the results shown in Table 6 were obtained. The sensory evaluation was shown by an average linguistic expression using a panel of Ikeda Institute for Food Research (5 persons).

【0037】[0037]

【表6】 すなわち、ブランク(EPA20 )とEPA20E(脱酸済油)区
(リン脂質無添加)の比較をすると、粉末化直後および
30日経過後共に、MGを含む後者においてはPOV が低
く、かつ、官能評価の結果も良好であり、MGを含むPU
FA含有油脂粉末の酸化安定性に関する本発明の効果が証
明されている。
[Table 6] In other words, comparing the blank (EPA20) and EPA20E (deoxidized oil) section (no phospholipid added),
After 30 days, in the latter containing MG, the POV was low and the results of sensory evaluation were also good.
The effect of the present invention on the oxidative stability of FA-containing oil and fat powder has been proved.

【0038】更に、EPA20E(脱酸済油)区について、リ
ン脂質無添加区とリン脂質添加区の比較をすると、リン
脂質を含む後者においては粉末化直後および30日経過後
共に、 POVが低く、かつ、官能評価の結果も良好であ
り、リン脂質を含むPUFA含有油脂粉末の酸化安定性に関
する本発明の効果が証明されている。
Further, when comparing the EPA20E (deoxidized oil) group with the phospholipid-free group and the phospholipid-added group, the latter containing phospholipid had a low POV both immediately after pulverization and after 30 days, Moreover, the result of the sensory evaluation was also good, and the effect of the present invention on the oxidation stability of the PUFA-containing oil and fat powder containing phospholipids has been proved.

【0039】[実施例4] 他抗酸化剤を配合したPUFA
含有油脂粉末との比較 食品、医薬品、及び飼料の分野でよく用いられる抗酸化
剤としてトコフェロールとアスコルビン酸を取り上げ、
本発明で用いられる PUFA-MG及びリン脂質の場合との比
較実験例を示す。処方を表7に示す。
Example 4 PUFA blended with other antioxidant
Comparison with oil and fat powder content Tocopherol and ascorbic acid are taken as antioxidants that are often used in the fields of foods, pharmaceuticals, and feeds.
An example of a comparative experiment with PUFA-MG and phospholipid used in the present invention is shown. The formulation is shown in Table 7.

【0040】[0040]

【表7】 実施例1と同様に、上記成分を混合・乳化処理した後、
同一方法でスプレードライヤーにて噴霧乾燥し製品を得
た。
[Table 7] After mixing and emulsifying the above components in the same manner as in Example 1,
The product was obtained by spray drying with a spray dryer in the same manner.

【0041】得られた粉末の品質を表8に示す。固形分
回収率は各区共、65〜70%である。官能評価は池田食研
研究所員(5名)をパネルとし、平均的な言語表現で示
した。
Table 8 shows the quality of the obtained powder. The solid content recovery rate is 65 to 70% in each section. The sensory evaluation was shown by an average linguistic expression using a panel of Ikeda Institute for Food Research (5 persons).

【0042】[0042]

【表8】 上記粉末の品質を 40 ℃(開放静置)条件下にて30日後
比較したところ、表9に示す結果が得られた。
[Table 8] When the qualities of the above powders were compared after 30 days under the condition of 40 ° C. (open standing), the results shown in Table 9 were obtained.

【0043】官能評価は池田食研研究所員(5名)をパ
ネルとし、平均的な言語表現で示してある。
The sensory evaluation is shown by an average linguistic expression with a panel of Ikeda Institute for Food Research (5 persons).

【0044】[0044]

【表9】 上記結果から下記のことが明確である。[Table 9] The following is clear from the above results.

【0045】1.EPA20 使用区(抗酸化剤無添加)とEP
A20E(脱酸済油)使用区(リン脂質無添加)のPOV の
値、官能評価(魚臭)等の比較から、MGを含むPUFA-M
G を用いることにより粉末化後の油脂の安定性は格段に
向上している。
1. EPA20 usage zone (no antioxidant added) and EP
From the comparison of POV value and sensory evaluation (fish odor) of A20E (deoxidized oil) use group (no phospholipid added), PUFA-M containing MG
By using G, the stability of fats and oils after pulverization is significantly improved.

【0046】2.EPA20 使用区(アスコルビン酸又はト
コフェロール添加)とEPA20E(脱酸済油)使用区(リン
脂質無添加)のPOV の値、官能評価(魚臭)等の比較か
ら、MGを含むPUFA-MG を用いることにより粉末化後の
油脂の安定性は、アスコルビン酸又はトコフェロールを
用いた場合よりも良好である。
2. PUFA-MG containing MG is used based on the comparison of POV value and sensory evaluation (fish odor) of EPA20 use group (with ascorbic acid or tocopherol added) and EPA20E (deoxidized oil) use group (without phospholipid added). As a result, the stability of fats and oils after pulverization is better than when ascorbic acid or tocopherol is used.

【0047】3.EPA20E(脱酸済油)使用区においてリ
ン脂質無添加とリン脂質添加の場合におけるPOV の値、
官能評価(魚臭)等の比較から、処方中にリン脂質を加
えることにより粉末化後の油脂の安定性は格段に向上し
ている。
3. The value of POV in the EPA20E (deoxidized oil) use group with and without phospholipid addition,
From the comparison of sensory evaluation (fish odor) and the like, the stability of the oil / fat after pulverization is significantly improved by adding phospholipid in the formulation.

【0048】以上の結果から、酸化安定性の高いPUFA含
有油脂粉末を得るに当たり、PUFA-MG を使用することの
有利性、酸化安定性をより高めるためにリン脂質を加え
ることの有利性等が実証された。
From the above results, in obtaining a PUFA-containing oil / fat powder having high oxidation stability, the advantages of using PUFA-MG and the advantages of adding phospholipids to further improve the oxidation stability are found. It was proven.

【0049】[0049]

【発明の効果】以上説明し、かつ実証した通り、本発明
は酸化安定性の高いPUFA含有油脂粉末の提供を通じて、
食品、医薬品、飼料等へのPUFAの利用範囲を拡大し、最
終的に、健康の維持、向上に寄与する事を可能とするも
のである。
As described and demonstrated above, the present invention provides the PUFA-containing oil and fat powder with high oxidation stability,
It is possible to expand the range of use of PUFA in foods, pharmaceuticals, feeds, etc., and ultimately contribute to the maintenance and improvement of health.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 A61K 35/78 J 7167−4C Q 7167−4C C 7167−4C C11B 5/00 2115−4H ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification number Office reference number FI Technical indication location A61K 35/78 J 7167-4C Q 7167-4C C 7167-4C C11B 5/00 2115-4H

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 モノグリセリドを含む高度不飽和脂肪酸
含有油脂中に存在するモノグリセリド含有量が重量比で
0.1%以上であることを特徴とする高度不飽和脂肪酸含
有油脂粉末。
1. The content of monoglyceride present in fats and oils containing polyunsaturated fatty acids containing monoglyceride is expressed by weight ratio.
A highly unsaturated fatty acid-containing oil / fat powder characterized by being 0.1% or more.
【請求項2】 モノグリセリドを含む高度不飽和脂肪酸
含有油脂の同粉末中への使用量が重量比で1.0 %以上で
あることを特徴とする請求項1記載の高度不飽和脂肪酸
含有油脂粉末。
2. The highly unsaturated fatty acid-containing fat powder according to claim 1, wherein the amount of the highly unsaturated fatty acid-containing fat containing monoglyceride in the powder is 1.0% or more by weight.
【請求項3】 モノグリセリドを含む高度不飽和脂肪酸
含有油脂中に存在する高度不飽和脂肪酸含有量が重量比
で 5.0%以上であることを特徴とする請求項1または2
記載の高度不飽和脂肪酸含有油脂粉末。
3. The polyunsaturated fatty acid content present in the polyunsaturated fatty acid-containing oil containing monoglyceride is 5.0% or more by weight ratio.
The highly-unsaturated fatty acid-containing oil and fat powder described.
【請求項4】 高度不飽和脂肪酸がα−リノレン酸、γ
−リノレン酸、ジホモ−γ−リノレン酸、アラキドン
酸、エイコサペンタエン酸、ドコサヘキサエン酸から選
ばれる1種類又は2種類以上の高度不飽和脂肪酸である
ことを特徴とする請求項1乃至3記載の高度不飽和脂肪
酸含有油脂粉末。
4. The polyunsaturated fatty acid is α-linolenic acid, γ
-Linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, one or more polyunsaturated fatty acids according to claim 1 to 3, characterized in that Oil and fat powder containing saturated fatty acids.
【請求項5】 高度不飽和脂肪酸含有油脂粉末中に含ま
れるモノグリセリドを含む高度不飽和脂肪酸含有油脂中
にリン脂質が重量比で 1.0%〜 30.0 %の範囲で含まれ
ることを特徴とする請求項1乃至4記載の高度不飽和脂
肪酸含有油脂粉末。
5. The phospholipid is contained in the highly unsaturated fatty acid-containing fat or oil containing the monoglyceride contained in the highly unsaturated fatty acid-containing fat or oil powder in a range of 1.0% to 30.0% by weight. The highly unsaturated fatty acid-containing oil and fat powder according to 1 to 4.
JP4330613A 1992-12-10 1992-12-10 Powder of fat and oil containing highly unsaturated fatty acid Withdrawn JPH06172782A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4330613A JPH06172782A (en) 1992-12-10 1992-12-10 Powder of fat and oil containing highly unsaturated fatty acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4330613A JPH06172782A (en) 1992-12-10 1992-12-10 Powder of fat and oil containing highly unsaturated fatty acid

Publications (1)

Publication Number Publication Date
JPH06172782A true JPH06172782A (en) 1994-06-21

Family

ID=18234624

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4330613A Withdrawn JPH06172782A (en) 1992-12-10 1992-12-10 Powder of fat and oil containing highly unsaturated fatty acid

Country Status (1)

Country Link
JP (1) JPH06172782A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08173134A (en) * 1994-12-22 1996-07-09 Asahi Chem Ind Co Ltd Egg alcoholic drink containing dha
JPH1084915A (en) * 1996-09-10 1998-04-07 Nippon Suisan Kaisha Ltd Fresh fish meat food
JPH10139673A (en) * 1996-11-06 1998-05-26 F Hoffmann La Roche Ag Pharmaceutical preparation
JPH10140178A (en) * 1996-09-10 1998-05-26 Nippon Suisan Kaisha Ltd Production of stabilized fat and oil, obtained fat and oil and food containing the fat and oil
JP2002145771A (en) * 2000-11-02 2002-05-22 Sankyo Shokuhin Kogyo Kk Powder of fat-soluble vitamin and powder of fat-soluble vitamin derivative and method for producing the same
JP2006298969A (en) * 2005-04-15 2006-11-02 Sanki Shoji Kk Highly unsaturated fatty acid containing fat and oil powder and method for producing the same
JP2007527862A (en) * 2003-07-15 2007-10-04 ディーエスエム アイピー アセッツ ビー.ブイ. Powdered formulation of fat-soluble active ingredients
EP2713725A4 (en) * 2011-05-31 2014-08-20 Cargill Inc Oxidatively-stabilized fats containing very long-chain omega-3 polyunsaturated fatty acids
JP2014212731A (en) * 2013-04-25 2014-11-17 上野製薬株式会社 Powdery oil
JP2017114776A (en) * 2015-12-21 2017-06-29 備前化成株式会社 Highly unsaturated fatty acid-containing compositions and foods containing composition thereof

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08173134A (en) * 1994-12-22 1996-07-09 Asahi Chem Ind Co Ltd Egg alcoholic drink containing dha
JPH1084915A (en) * 1996-09-10 1998-04-07 Nippon Suisan Kaisha Ltd Fresh fish meat food
JPH10140178A (en) * 1996-09-10 1998-05-26 Nippon Suisan Kaisha Ltd Production of stabilized fat and oil, obtained fat and oil and food containing the fat and oil
JPH10139673A (en) * 1996-11-06 1998-05-26 F Hoffmann La Roche Ag Pharmaceutical preparation
JP2002145771A (en) * 2000-11-02 2002-05-22 Sankyo Shokuhin Kogyo Kk Powder of fat-soluble vitamin and powder of fat-soluble vitamin derivative and method for producing the same
JP2007527862A (en) * 2003-07-15 2007-10-04 ディーエスエム アイピー アセッツ ビー.ブイ. Powdered formulation of fat-soluble active ingredients
JP2006298969A (en) * 2005-04-15 2006-11-02 Sanki Shoji Kk Highly unsaturated fatty acid containing fat and oil powder and method for producing the same
EP2713725A4 (en) * 2011-05-31 2014-08-20 Cargill Inc Oxidatively-stabilized fats containing very long-chain omega-3 polyunsaturated fatty acids
JP2014212731A (en) * 2013-04-25 2014-11-17 上野製薬株式会社 Powdery oil
JP2017114776A (en) * 2015-12-21 2017-06-29 備前化成株式会社 Highly unsaturated fatty acid-containing compositions and foods containing composition thereof

Similar Documents

Publication Publication Date Title
US8048652B2 (en) Biomass hydrolysate and uses and production thereof
JP3040477B2 (en) Microencapsulated oil or fat products
KR100951756B1 (en) Oil composition
ES2300115T3 (en) EDIBLE FATS CONTAINING ARACHIDONIC ACID AND FOODS CONTAINING THE SAME.
JP4685355B2 (en) Process for producing oil and fat composition containing licorice hydrophobic component
JP2008088181A (en) PRODUCTION AND USE OF POLAR LIPID-RICH FRACTION CONTAINING omega-3 AND/OR omega-6 HIGHLY UNSATURATED FATTY ACID(S) DERIVED FROM MICROORGANISM, GENETICALLY-MODIFIED PLANT SEED AND MARINE ORGANISM
CN107846960B (en) Microcapsules containing stable lipids and method for preparing same
WO2005104865A1 (en) Fat composition
CN106715381B (en) Fatty acid composition and method for fortifying a nutritional product with fatty acids
US4794015A (en) Process for emulsifying fat or oil into aqueous phase comprising soy sauce as the main component
JPH07305088A (en) Powdery oil and fat composition
JPH06172782A (en) Powder of fat and oil containing highly unsaturated fatty acid
KR19980701316A (en) Stabilizing agent for oleaginous, physiologically active substances
Rossi Use of lecithin and lecithin fractions
JPH09187249A (en) Production of emulsified or powdered functional material
JPH0930962A (en) Medical oil and fat-containing composition
JP2002514394A (en) Use of nanofoods in human and animal food end products
JP3482253B2 (en) Cooking fats and oils
JP3222314B2 (en) Method for producing fat powder containing polyunsaturated fatty acids
JPH05137506A (en) Powdered fats and oils and its production
JP2004018678A (en) Sterol fatty acid ester composition and foodstuff containing the same
JPH0748992B2 (en) Powder composition for preventing thrombus
JP3027858B2 (en) Method for producing highly unsaturated fatty acid-containing composition
JP2002238500A (en) Tocopherol preparation suppressed in deterioration of flavor and food and drink obtained by formulating the same
JP2006296411A (en) Aqueous mixed body containing high-grade aliphatic compound

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20000307